Navigation Links
Mpex Pharmaceuticals Announces Initiation of a Phase 2 Clinical Trial of Aerosol MP-376 in COPD
Date:11/3/2008

SAN DIEGO, Nov. 3 /PRNewswire/ -- Mpex Pharmaceuticals, Inc. today announced that it has initiated a Phase 2 clinical study with MP-376 for use as a maintenance therapy in reducing the incidence of pulmonary exacerbations in patients with chronic obstructive pulmonary disease (COPD). MP-376 is the company's novel formulation of levofloxacin inhalation solution.

The Phase 2, U.S. multi-center randomized, double-blind, placebo-controlled study (Mpex 302) is expected to enroll approximately 300 COPD patients to evaluate the safety, tolerability and efficacy of 5 days of dosing every 28 days, for up to 12 treatment cycles. Inclusion criteria are designed to enroll patients at high risk for acute exacerbations. The primary efficacy endpoint in this study is a comparison of the rate of acute exacerbations in patients treated with MP-376 versus placebo control. Additional endpoints will include the number, duration and severity of acute exacerbations, lung function, quality of life and functional status.

Chronic bacterial infection of the lower airways of patients with COPD results in inflammation that causes lung damage, as well as predisposes patients to acute exacerbations that arise from a variety of causes. Bacterial infections are a leading cause of these exacerbations and antibiotics are widely used to treat exacerbations when they occur. Although several bronchodilators and anti-inflammatory agents have been licensed for maintenance treatment, there are currently no inhaled antibiotics that are cleared for use in the U.S. for preventing the root cause of these exacerbations.

"There is significant enthusiasm in the clinical community for an inhaled antibiotic that can reduce the incidence of acute exacerbations in COPD in high risk patients," stated Dr. Jeff Loutit, Chief Medical Officer of Mpex Pharmaceuticals. "A therapy that addresses the underlying issues associated with COPD to reduce exacerbations would be highly beneficial and pote
'/>"/>

SOURCE Mpex Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
2. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
3. Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor
4. Minster Pharmaceuticals Plc Announces Positive Results from Phase II Trial of Migraine with Aura
5. Addrenex Pharmaceuticals Initiates Phase 2 Trial on Its Novel Hypertension Drug, ADX415
6. Oramed Pharmaceuticals Launches Phase 1A Trials of its Insulin Suppository
7. Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis
8. /K I L L K I L L K I L L -- Oramed Pharmaceuticals Inc./
9. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
10. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
11. Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)...  SI-BONE, Inc., a medical device company that pioneered ... the sacroiliac (SI) joint with the iFuse Implant System ... have now been performed world wide utilizing more than ... iFuse procedure continues to grow and gain momentum with ... the United States and 17 countries ...
(Date:3/2/2015)... BETHESDA, Md. , March 2, 2015  Celimmune ... and preventing autoimmune diseases, announced today that it has ... from Amgen (NASDAQ: AMGN ). Under the ... rights to develop, manufacture and commercialize AMG 714 on ... Concurrently, Amgen has been granted an exclusive option to ...
(Date:3/2/2015)... ANGELES , March 2, 2015 ImmunoCellular Therapeutics, Ltd. ... financial results for the year ended December 31, 2014 on March ... conference call and webcast on Thursday, March 12, 2015, at 5:00 ... , President and CEO.   , ... dial-in: (631) 291-4544; conference code 92238648. , , , ...
Breaking Medicine Technology:SI-BONE, Inc. Announces 15,000 iFuse Procedure Milestone 2SI-BONE, Inc. Announces 15,000 iFuse Procedure Milestone 3Celimmune Announces Anti-IL-15 Antibody Licensing and Option Agreements with Amgen 2Celimmune Announces Anti-IL-15 Antibody Licensing and Option Agreements with Amgen 3ImmunoCellular Therapeutics to Report 2014 Financial Results on March 9, 2015; a Business Update Conference Call and Webcast is Scheduled for March 12, 2015 2
... JOSEPH, Mo., April 14, 2011 On Monday, April ... Veterinary cardiologists on the Mobile Dog Heart Health Tour ... free dog heart examinations at Seger Dog Park. ... to providing free heart health screenings, veterinarians will be ...
... GlaxoSmithKline (GSK) is committed to ensuring that consumers and ... alli is safe and effective when used as directed. ... locally in the gastro-intestinal tract. GSK continues to proactively ... relevant information with regulatory agencies. Since orlistat ...
Cached Medicine Technology:Veterinarians to Perform Free Dog Heart Health Screenings in Philadelphia on April 18 2Veterinarians to Perform Free Dog Heart Health Screenings in Philadelphia on April 18 3
(Date:3/2/2015)... 02, 2015 The Alliance for Bangladesh ... expert Mark Chubb to serve as chief safety officer. ... and training in Bangladesh and guide remediation efforts in ... “Mark will ensure that the Alliance continues to bring ... for Bangladesh garment workers,” said Alliance Independent Chair Ellen ...
(Date:3/2/2015)... Viejo, California (PRWEB) March 02, 2015 ... release of the TranStatic Volume 2 from Pixel Film Studios. ... transitions made exclusively for FCPX,” said Christina Austin, CEO of ... to have in any Final Cut Pro X editors toolbox.” ... scene to the next with media altering static scrambling effects ...
(Date:3/1/2015)... 2015 As residents and business ... Michael Burns and Carita Weaver, believe in supporting ... with the Southlake Chamber of Commerce, Carroll Independent ... recently launched a website for Southlake mayoral candidate ... communications tool for Hill’s campaign, the website combines ...
(Date:3/1/2015)... 2015 Adults who are not legally ... term or universal policies can now use the QuotesPros.com ... life insurance companies for single adults can now be ... http://quotespros.com/life-insurance.html . , The rate plans that nationwide agencies ... to a number of life protection policies. The term, ...
(Date:3/1/2015)... 2015 The number of transvaginal mesh ... past few weeks in two New Jersey litigations where ... the Firm announces. , A Case List updated ... Bergen County proceeding established for products manufactured by Johnson ... weeks earlier, when 90 fewer cases had been centralized. ...
Breaking Medicine News(10 mins):Health News:Alliance for Bangladesh Worker Safety Names New Chief Safety Officer 2Health News:Pixel Film Studios released the TranStatic Volume 2 plugin for Final Cut Pro X today 2Health News:Website Launched for Southlake, Texas Mayoral Candidate Laura Hill 2Health News:Best Life Insurance Companies for Single Adults Now Searchable at Insurance Website 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 3Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 4
... on Finding Solutions to Healthcare Crisis Affecting Communities of ... Voices: Healthcare for the Underserved today announced the second ... to be held April 30 - May 1, 2009 ... The conference, themed "Strengthening Families During Incarceration and ...
... animal testing encouragingBELGRADE, Serbia, Feb. 2 /PRNewswire-FirstCall/ - ... announced the results of preliminary testing of a ... the use of a combination of drugs; ribavirin ... ribavirin and tiazofurin in combination attenuated or weakened ...
... surgery for acute shoulder dislocation may provide the best ... million children and adolescents participate in organized athletics and ... of shoulder injuries that occur in these young athletes ... to a paper published in the February 2009 issue ...
... U.S. Department of Health and Human Services (HHS) ... standards developed by the Healthcare Information Technology ... Specifications" - documents that harmonize and recommend the ... electronic health records and help support the nationwide ...
... of fibroblasts during development also promotes their ability to ... in the February 9, 2009 issue of the ... epithelial cells into fibroblast-like mesenchymal cells is a critical ... factor Snail1 induces this conversion (known as epithelialmesenchymal transition, ...
... An online survey of 1,888,physicians, medical group ... U.S. physician groups are eager to accept a ... incentives,designed to promote broader adoption of information technologies ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) , ...
Cached Medicine News:Health News:Community Voices: Healthcare for the Underserved Announces Second Annual Freedom's Voice Conference and Awards Gala 2Health News:Community Voices: Healthcare for the Underserved Announces Second Annual Freedom's Voice Conference and Awards Gala 3Health News:Hard To Treat Diseases (HTDS) Announces Initial Research Results on Potential MS Therapy 2Health News:Immediate Orthopaedic Care Can Help Heal a Young Athlete's Shoulder 2Health News:Immediate Orthopaedic Care Can Help Heal a Young Athlete's Shoulder 3Health News:HHS Secretary Recognizes Products of HITSP Standards Work 2Health News:HHS Secretary Recognizes Products of HITSP Standards Work 3Health News:HHS Secretary Recognizes Products of HITSP Standards Work 4Health News:Fibroblasts invade at a snail's pace 2Health News:Allscripts Survey of Healthcare Professionals Demonstrates Potential Impact of Economic Stimulus Plan on Electronic Health Record Adoption 2Health News:Allscripts Survey of Healthcare Professionals Demonstrates Potential Impact of Economic Stimulus Plan on Electronic Health Record Adoption 3Health News:Allscripts Survey of Healthcare Professionals Demonstrates Potential Impact of Economic Stimulus Plan on Electronic Health Record Adoption 4Health News:Allscripts Survey of Healthcare Professionals Demonstrates Potential Impact of Economic Stimulus Plan on Electronic Health Record Adoption 5Health News:Allscripts Survey of Healthcare Professionals Demonstrates Potential Impact of Economic Stimulus Plan on Electronic Health Record Adoption 6Health News:Allscripts Survey of Healthcare Professionals Demonstrates Potential Impact of Economic Stimulus Plan on Electronic Health Record Adoption 7Health News:Allscripts Survey of Healthcare Professionals Demonstrates Potential Impact of Economic Stimulus Plan on Electronic Health Record Adoption 8Health News:Allscripts Survey of Healthcare Professionals Demonstrates Potential Impact of Economic Stimulus Plan on Electronic Health Record Adoption 9
... the pioneers of surgical lighting, including ... automatic reserve bulb, an integrated surgical ... sets the standard for advanced lighting ... our latest generation surgical light ...
... SimpliCT® is an interventional guidance device ... significantly improve the accuracy of computed ... to improving accuracy, SimpliCT® also has ... of CT-guided puncture procedures including biopsies ...
Flat tip, bare fiber, no cooling, polished SMA 905, 3 meters long. Sold in boxes of five. Each part is individually packaged in sterile Tyvek bags....
Get YAG laser performance from your diode laser. Our proprietary NA shift technology offers efficient coupling of low divergence fiber to high divergence lasers...
Medicine Products: